The DOI matches its Crossref record; 159 of the 165 references it cites were found in a registry or an index.
Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis
Abstract
Multiple theories of Attention-Deficit/Hyper-activity Disorder (ADHD) have been proposed, but one that has stood the test of time is the dopamine deficit theory. We review the narrow literature from recent brain imaging and molecular genetic studies that has improved our understanding of the role of dopamine in manifestation of symptoms of ADHD, performance deficits on neuropsychological tasks, and response to stimulant medication that constitutes the most common treatment of this disorder. First, we consider evidence of the presence of dopamine deficits based on the recent literature that (1) confirms abnormalities in dopamine-modulated frontal-striatal circuits, reflected by size (smaller-than-average components) and function (hypoactivation); (2) clarifies the agonist effects of stimulant medication on dopaminergic mechanisms at the synaptic and circuit level of analysis; and (3) challenges the most-widely accepted ADHD-related neural abnormality in the dopamine system (higher-than-normal dopamine transporter [DAT] density). Second, we discuss possible genetic etiologies of dopamine deficits based on recent molecular genetic literature, including (1) multiple replications that confirm the association of ADHD with candidate genes related to the dopamine receptor D4 (DRD4) and the DAT; (2) replication of differences in performance of neuropsychological tasks as a function of the DRD4 genotype; and (3) multiple genome-wide linkage scans that demonstrate the limitations of this method when applied to complex disorders but implicate additional genes that may contribute to the genetic basis of ADHD. Third, we review possible environmental etiologies of dopamine deficits based on recent studies of (1) toxic substances that may affect the dopamine system in early development and contribute substantially to the etiology of ADHD; (2) fetal adaptations in dopamine systems in response to stress that may alter early development with lasting effects, as proposed by the developmental origins of health and disease hypothesis; and (3) gene-environment interactions that may moderate selective damage or adaptation of dopamine neurons. Based on these reviews, we identify critical issues about etiologic subtypes of ADHD that may involve dopamine, discuss methods that could be used to address these issues, and review old and new theories that may direct research in this area in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This neuromodulatory system is implicated in ADHD (Swanson et al., 2007; Volkow et al., 2009) and may affect both emotional and non-emotional processing.”
From Top-Down Dysregulation—From ADHD to Emotional Instability (2016) · cites this paper as Swanson et al., 2007
In the citing paper
“Regarding the latter, changes in dopaminergic signaling have long been implicated in ADHD ( [48], but see [49])”
From Linking ADHD to the Neural Circuitry of Attention (2017) · cites this paper as [48]
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,889
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
The American Journal of Human Genetics
S., J. (1950) · Population · doi:10.2307/1523704 · Cited by 5,124
Role of genotype in the cycle of violence in maltreated children
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., & Poulton, R. (2002) · Science · doi:10.1126/science.1072290 · Cited by 4,842
WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90710-1 · Cited by 3,574
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Research works printed but not linked: 4
- Hesse, S., Ballaschkle, O., Barthel, H., von Cramon, D., & Sabri, O. (2006). The striatal dopamine transporter availability is reduced in adults with attention-deficit/hyperactivity disorder. Journal of Nuclear Medicine, 47, 142.
- MTA Cooperative Group. (1999). Multimodal treatment study of children with ADHD. A 140 month randomized clinical trail of treatment strategies for attention deficit/hyperactivity disorder. Archive of General Psychiatry, 56, 1073–1086. · DOI · Paper page
- Nigg, J. T. (2006). What causes ADHD? Toward a multi-path model for understanding what goes wrong and why. New York: Guilford Press.
- Posner, M. I., & Raichle, M. E. (1994). Images of mind. New York: Scientific American Library.
Cited by
Sorted by citations
Items 201–300 of 580
Li, J. J., & Lee, S. S. (2011) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-011-9553-z · Cited by 41
Warton, F. L., Howells, F. M., & Russell, V. A. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-009-9166-1 · Cited by 37
Ruocco, L. A., Silva, M. A. D. S., Topic, B., Mattern, C., Huston, J. P., & Sadile, A. G. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.005 · Cited by 38
Wei, C., Chang, C., Lin, C., Chang, S., Li, T., & Kao, C. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12303 · Cited by 35
Exploring the genetic link between RLS and ADHD
SCHIMMELMANN, B. G., Friedel, S., Nguyen, T. T., Sauer, S., Vogel, C. I. G., Konrad, K., Wilhelm, C., Sinzig, J., Renner, T., Romanos, M., et al. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.01.003 · Cited by 37
Connolly, J. J., Glessner, J., Kao, C., Elia, J., & Hakonarson, H. H. (2015) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479015599811 · Cited by 43
East, P. L., Doom, J. R., Blanco, E., Burrows, R., Lozoff, B., & Gahagan, S. (2023) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2021.1969653 · Cited by 36
“That is, ADHD has been studied as a dopamine deficit (Swanson et al., 2007; Tripp & Wickens, 2008), as resulting from dysregulated myelination (Konrad & Eickhoff, 2010; Lesch, 2019), and as a disconnection between brain regions that support the default-mode network (Cao et al., 2014; Konrad et al.,…”
BackgroundNeuromodulator regulation and emotions: insights from the crosstalk of cell signaling
Tsuboi, D., Nagai, T., Yoshimoto, J., & Kaibuchi, K. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1376762 · Cited by 37
Degremont, A., Jain, R., Philippou, E., & Latunde-Dada, G. O. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa065 · Cited by 36
Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD
Rydén, E., Johansson, C., Blennow, K., & Landén, M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0300-3 · Cited by 36
Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients
Martínez-Levy, G. A., John, D.-G., Briones-Velasco, M., Gómez‐Sánchez, A., Francisco, D. L. P.-O., Mora, L. S., Palacios‐Cruz, L., Ricardo-Garcell, J., Reyes-Zamorano, E., & Carlos, C.-F. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.004 · Cited by 36
Lakes, K. D., Vargas, D. A., Riggs, M. L., Schmidt, J., & Baird, M. (2010) · Journal of Child and Family Studies · doi:10.1007/s10826-010-9440-1 · Cited by 42
Attention deficit hyperactivity disorder may be a highly inflammation and immune-associated disease
Zhou, R., Wang, J., Sun, J., You, Y., Ying, J.-N., & Han, X.-M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7228 · Cited by 36
on behalf of the “Lombardy ADHD Registry Group”, Didoni, A., Sequi, M., Panei, P., & Bonati, M. R. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1050-3 · Cited by 36
Itoh, S., Yamazaki, K., Suyama, S., Araki, A., Miyashita, C., Bamai, Y. A., Kobayashi, S., Masuda, H., Yamaguchi, T., Goudarzi, H., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.107026 · Cited by 39
DRD4 genotype moderates the impact of parental problems on unresolved loss or trauma
Bakermans-Kranenburg, M. J., van IJzendoorn, M. H., Caspers, K., & Philibert, R. (2011) · Attachment & Human Development · doi:10.1080/14616734.2011.562415 · Cited by 34
Wang, Y., SAMUELS, J. F., Chang, Y.-P. C., Grados, M. A., Greenberg, B. D., Knowles, J. A., McCracken, J. T., Rauch, S. L., Murphy, D. L., Rasmussen, S. A., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30760 · Cited by 34
Kim, J. W., Kim, B.-N., Lee, J., Na, C., Kee, B., Min, K., Han, D., Kim, J., & Lee, Y.-S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145288 · Cited by 35
Pain hypersensitivity in a pharmacological mouse model of attention-deficit/hyperactivity disorder
Bouchatta, O., Aby, F., Sifeddine, W., Bouali‐Benazzouz, R., Brochoire, L., Manouze, H., Fossat, P., Ba-M’hamed, S., Bennis, M., & Landry, M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114094119 · Cited by 34
Hong, S.-B., Kim, J.-W., Choi, B.-S., Hong, Y., Park, E. J., Shin, M., Kim, B., Yoo, H., Cho, I.-H., Bhang, S., et al. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.049 · Cited by 34
Bergwerff, C. E., Luman, M., Blom, H., & Oosterlaan, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151100 · Cited by 34
Neuropsychological Assessment and The Paradox of ADHD
Koziol, L. F., & Stevens, M. C. G. (2012) · Applied Neuropsychology Child · doi:10.1080/21622965.2012.694764 · Cited by 36
França, A. P., Schamne, M. G., de Souza, B. S., Scheffer, D. D. L., Bernardelli, A. K., Corrêa, T., Izídio, G. S., Latini, A., da Silva‐Santos, J. E., Canas, P. M., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02002-4 · Cited by 33
Gonon, F., Guilé, J.-M., & Cohen, D. (2010) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2010.02.004 · Cited by 42
Hawi, Z., Matthews, N. L., Barry, E., Kirley, A., Wagner, J., Wallace, R. H., Heussler, H., Vance, A. L. A., Gill, M., & Bellgrove, M. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2875-x · Cited by 32
Silvetti, M., Wiersema, J. R., Sonuga-Barke, E. J. S., & Verguts, T. (2013) · Neural Networks · doi:10.1016/j.neunet.2013.05.008 · Cited by 36
Willoughby, M. T., Blanton, Z. E., & Family Life Project Investigators (2013) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2013.850702 · Cited by 34
Genetic Insights Into ADHD Biology
Hayman, V., & Fernandez, T. V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00251 · Cited by 32
Dopamine-Dependent Periadolescent Maturation of Corticostriatal Functional Connectivity in Mouse
Galiñanes, G. L., Taravini, I. R. E., & Murer, M. G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4421-08.2009 · Cited by 33
Background, clinical features and treatment of attention deficit hyperactivity disorder in children
Warikoo, N., & Faraone, S. V. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.818977 · Cited by 33
Heinonen, K., Räikkönen, K., Pesonen, A., ANDERSSON, S. M., Kajantie, E., Eriksson, J. G., Vartia, T., Dieter Wolke, C., & Lano, A. (2011) · BMC Pediatrics · doi:10.1186/1471-2431-11-84 · Cited by 31
Zhang, J., Yuan, M., Liu, Y., Zhong, X., Wu, J., & Chen, W. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137731 · Cited by 31
Zamorano, F. J., Kausel, L., Albornoz, C., Lavín, C., Figueroa-Vargas, A., Stecher, X., Aragón‐Caqueo, D., Carrasco, X., Aboitiz, F., & Billeke, P. B. (2020) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2020.00037 · Cited by 30
Schlagal, C. R., Dunn, T. J., Xu, P., Felsing, D. E., Merritt, C. R., Manja, S., Fox, R. G., Buffington, S. A., Saade, G. R., Dineley, K. T., et al. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.03.014 · Cited by 29
Hollis, C. P., Groom, M. J., Das, D., Calton, T., Bates, A. T., Andrews, H., Jackson, G. M., & Liddle, P. F. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.010 · Cited by 30
Baumgardner, D. J., Schreiber, A. L., Havlena, J. A., Bridgewater, F. D., Steber, D. L., & Lemke, M. A. (2010) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.40.4.a · Cited by 30
Hidas, A., Birman, N., Fux‐Noy, A., Shapira, J., Matot, I., Steinberg, D., & Moskovitz, M. (2012) · Clinical Oral Investigations · doi:10.1007/s00784-012-0876-0 · Cited by 30
Quantitative EEG (QEEG) in psychiatry: Diagnostic or prognostic use?
Arns, M., & Gordon, E. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.01.014 · Cited by 31
Oh, J., Kim, K., Kannan, K., Parsons, P. J., Mlodnicka, A., Schmidt, R. J., Schweitzer, J. B., Hertz‐Picciotto, I., & Bennett, D. H. (2024) · Environmental Health · doi:10.1186/s12940-024-01065-3 · Cited by 29
Systematic overview of neuroanatomical differences in ADHD: Definitive evidence
de Melo, B. B. V., Trigueiro, M. J., & Rodrigues, P. P. (2017) · Developmental Neuropsychology · doi:10.1080/87565641.2017.1414821 · Cited by 32
ADHD, lead exposure and prevention: how much lead or how much evidence is needed?
Nigg, J. T. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.519 · Cited by 28
Self-citationAdisetiyo, V., Gray, K. M., Jensen, J. H., & Helpern, J. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101993 · Cited by 30
Neurobehavioural characterisation and stratification of reinforcement-related behaviour
Jia, T., Ing, A., Quinlan, E. B., Tay, N., Luo, Q., Biondo, F., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Bromberg, U., et al. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-0846-5 · Cited by 27
Associations between psychotic-like symptoms and inattention/hyperactivity symptoms
Hurtig, T. M., Taanila, A. M., Veijola, J. M., Ebeling, H. E., Mäki, P. H., Miettunen, J., Kaakinen, M., Joukamaa, M. I., Therman, S., Heinimaa, M., et al. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0165-7 · Cited by 27
Plomp, E., van Engeland, H., & Durston, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.024 · Cited by 28
Sun, J., Han, X., Xianguo, R., Dongqi, Y., Rongyi, Z., Shuang, L., You, Y., Yuchen, S., & Jingnan, Y. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/2695903 · Cited by 28
Lorenz, R. C., Gleich, T., Buchert, R., Schlagenhauf, F., Kühn, S., & Gallinat, J. (2015) · Human Brain Mapping · doi:10.1002/hbm.22895 · Cited by 29
Khoshbakht, Y., Moghtaderi, F., Bidaki, R., Hosseinzadeh, M., & Salehi-Abargouei, A. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02527-x · Cited by 27
Islam, K., Seth, S., Saha, S., Roy, A., Das, R., & Datta, A. (2018) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_197_17 · Cited by 26
Ferritin and hyperactivity ratings in attention deficit hyperactivity disorder
Öner, P., Öner, Ö., Azik, F. M., Çöp, E., & Münir, K. (2012) · Pediatrics International · doi:10.1111/j.1442-200x.2012.03664.x · Cited by 26
Arcos-Burgos, M., Londoño, A. C., Pineda, D. A., Lopera, F., Palacio, J. D., Arbelaez, A., Acosta, M. T., Vélez, J. I., Castellanos, F. X., & Muenke, M. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0088-0 · Cited by 26
Self-citationNicotine-induced impulsive action
Kirshenbaum, A. P., Jackson, E. R., Brown, S. J., Fuchs, J. R., Miltner, B. C., & Doughty, A. H. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328345ca1c · Cited by 26
Udal, A. H., Øygarden, B., Egeland, J., Malt, U. F., Lövdahl, H., Pripp, A. H., & Grøholt, B. (2012) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104512455181 · Cited by 26
Yordanova, J., Kolev, V., Albrecht, B., Uebel, H., Banaschewski, T., & Rothenberger, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.026 · Cited by 26
Jan, R. K., Lin, J. C., McLaren, D. G., Kirk, I. J., Kydd, R. R., & Russell, B. R. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00020 · Cited by 26
NCAM1‐TTC12‐ANKK1‐DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD
Mota, N. R., Rovaris, D. L., Kappel, D. B., Picon, F. A., Vitola, E. S., Salgado, C. A. I., Karam, R. G., Rohde, L. A., Grevet, E. H., & Bau, C. H. D. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32317 · Cited by 25
Lewis, N., Villani, A., & Lagopoulos, J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.01.031 · Cited by 25
Thiol disulfide homeostasis in psychiatric disorders: A comprehensive review
Tunçay, M. E., Atagün, M. İ., & Erel, Ö. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110719 · Cited by 25
Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals
Qi, Z., Miller, G. W., & Voit, E. O. (2009) · Synapse · doi:10.1002/syn.20686 · Cited by 25
Hiraide, S., Ueno, K.-I., Yamaguchi, T., Matsumoto, M., Yanagawa, Y., Yoshioka, M., & Togashi, H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.009 · Cited by 24
Response monitoring in children with phenylketonuria.
Araujo, G. C., Christ, S. E., Steiner, R. D., Grange, D. K., Nardos, B., McKinstry, R. C., & White, D. A. (2009) · Neuropsychology · doi:10.1037/a0013488 · Cited by 24
Li, S., Passow, S., Nietfeld, W., Schröder, J., Bertram, L., Heekeren, H. R., & Lindenberger, U. (2013) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.04.005 · Cited by 25
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics
Turic, D. (2010) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s6800 · Cited by 25
Strengths and limitations of genetic models of ADHD
Gainetdinov, R. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0021-3 · Cited by 24
Waly, M. I., Hornig, M., Trivedi, M. S., Hodgson, N., Kini, R., Ohta, A., & Deth, R. C. (2012) · Autism Research and Treatment · doi:10.1155/2012/190930 · Cited by 23
Parenting and Family Diversity Issues
Lang, D. (2020) · doi:10.31274/isudp.8 · Cited by 23
Accurate Identification of ADHD among Adults Using Real-Time Activity Data
Kaur, A., & Kahlon, K. S. (2022) · Brain Sciences · doi:10.3390/brainsci12070831 · Cited by 23
Wang, Y., Hu, D., Chen, W., Xue, H.-L., & Du, Y.-K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40850-w · Cited by 22
Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene
Gehricke, J., Swanson, J. M., Duong, S., Nguyen, J., Wigal, T. L., Fallon, J., Caburian, C., Muftuler, L. T., & Moyzis, R. K. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.10.021 · Cited by 23
Self-citationGuimarães, A. P., Schmitz, M. D., Polanczyk, G. V., Zeni, C., Genro, J. P., Roman, T., Rohde, L. A., & Hutz, M. H. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0305-y · Cited by 25
Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast
Easton, N., Marshall, F. H., Marsden, C. A., & Fone, K. C. F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.018 · Cited by 22
Johansen, E. B., Knoff, M., Fonnum, F., Lausund, P. L., Walaas, S. I., Wøien, G., & Sagvolden, T. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-18 · Cited by 22
Baca, M., Allan, A. M., Partridge, L., & Wilson, M. C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.012 · Cited by 22
Jiménez‐Figueroa, G., Ardila-Duarte, C., Pineda, D. A., Acosta-López, J. E., Cervantes-Henríquez, M. L., Pineda‐Alhucema, W., Cervantes-Gutiérrez, J., Quintero-Ibarra, M., Sánchez-Rojas, M., Velez, J. I., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-017-0223-z · Cited by 24
Human Brain Imaging Links Dopaminergic Systems to Impulsivity
London, E. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_125 · Cited by 22
Elliott, B. L., D’Ardenne, K., Mukherjee, P., Schweitzer, J. B., & McClure, S. M. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.05.002 · Cited by 23
Attention deficit hyperactivity disorder and risk of migraine: A nationwide longitudinal study
Hsu, T., Chen, M., Chu, C., Tsai, S., Bai, Y., Su, T., Chen, T., & Liang, C. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14306 · Cited by 22
A review of psychostimulant-induced neuroadaptation in developing animals
CARREY, N. J., & Wilkinson, M. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1004-x · Cited by 21
Braz, B. Y., Galiñanes, G. L., Taravini, I. R. E., Belforte, J. E., & Murer, M. G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.104 · Cited by 21
Pauli‐Pott, U., Dalir, S., Mingebach, T., Roller, A., & Becker, K. (2013) · Child Neuropsychology · doi:10.1080/09297049.2013.778236 · Cited by 22
Baicalin may have a therapeutic effect in attention deficit hyperactivity disorder
Zhou, R., Han, X.-M., Wang, J., & Sun, J. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.012 · Cited by 21
Rapoport, I. L., & Groenman, A. P. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251315601 · Cited by 25
Zhong, P., Liu, W., & Yan, Z. (2015) · The Journal of Physiology · doi:10.1113/jp271317 · Cited by 20
Aguilar, J. I., Cheng, M. H., Font, J. S., Schwartz, A. C., Ledwitch, K. V., Duran, A. M., Mabry, S. J., Belovich, A. N., Zhu, Y., Carter, A. M., et al. (2021) · eLife · doi:10.7554/elife.68039 · Cited by 19
O’Neill, S. C. (2010) · Issues in clinical child psychology · doi:10.1007/978-1-4419-5800-6_23 · Cited by 20
On the Treatment and Diagnosis of Attention Deficit Hyperactivity Disorder with EEG Assistance
Freismuth, D., & TaheriNejad, N. (2022) · Electronics · doi:10.3390/electronics11040606 · Cited by 19
The Evolution of Cognitive Search
(2012) · The MIT Press eBooks · doi:10.7551/mitpress/9529.003.0006 · Cited by 19
Kasahara, S., Takahashi, K., Matsudaira, K., Sato, N. S., Fukuda, K., Toyofuku, A., Yoshikawa, T., Kato, Y., Niwa, S., & Uchida, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-28931-3 · Cited by 19
ADHD symptoms, breast‐feeding and obesity in children and adolescents
Türkoğlu, S., Bi̇lgi̇ç, A., & Akça, Ö. F. (2015) · Pediatrics International · doi:10.1111/ped.12593 · Cited by 19
Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder
Jacqz-Aigrain, É., Konofal, É., Zhao, W., Lecendreux, M., Kaguelidou, F., Benadjaoud, L., Mentré, F., & Laouenan, C. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s65495 · Cited by 19
Büber, A., Çakaloz, B., Işıldar, Y., Ünlü, G., Bostancı, H. E., Aybek, H., & Herken, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.016 · Cited by 18
Are children affected by epileptic neuropsychiatric comorbidities?
Terra, V. C., de Paola, L., & Silvado, C. E. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.003 · Cited by 18
Understanding the ADHD-Gut Axis by Metabolic Network Analysis
Taş, E., & Ülgen, K. Ö. (2023) · Metabolites · doi:10.3390/metabo13050592 · Cited by 18
Moore, T. M., Brown, T., Cade, M., & Eells, J. B. (2008) · Synapse · doi:10.1002/syn.20550 · Cited by 18
The use of lisdexamfetamine dimesylate for the treatment of ADHD
Childress, A. C., & Sallee, F. R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.175 · Cited by 18
Dan, O. (2020) · Journal of Adolescence · doi:10.1016/j.adolescence.2020.04.010 · Cited by 24
Qin, L., Liu, W., Ma, K., Wei, J., Zhong, P., Cho, K., & Yan, Z. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.024 · Cited by 18
Jepsen, J. R. M., Rydkjær, J., Fagerlund, B., Pagsberg, A. K., Jespersen, R. A. F., Glenthoj, B. Y., & Oranje, B. (2017) · Psychological Medicine · doi:10.1017/s0033291717001921 · Cited by 18
Stein, Z. (2010) · Mind Brain and Education · doi:10.1111/j.1751-228x.2010.01085.x · Cited by 19
Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain
Urban, K. R., & Gao, W. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712455504 · Cited by 18
Metadata
- Authors
- Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G. A., Volkow, N., Taylor, E., Casey, B. J., Castellanos, F. X., & Wadhwa, P. D.
- Affiliations
- University of California, Irvine (US)
- The New School (US)
- Michigan State University (US)
- Cincinnati Children's Hospital Medical Center (US)
- Jefferson Einstein Philadelphia Hospital (US)
- Brookhaven National Laboratory (US)
- Cornell University (US)
- New York University (US)
- Corresponding author
- Swanson, James M.
- ORCID
- Venue
- Neuropsychology Review
- Published
- 2007-02-21
- Volume
- 17
- Issue
- 1
- Pages
- 39-59
- ISSN
- 1040-7308 (ISSN-L)
- 1573-6660
- OpenAlex
- W2098273438
- Cited by
- 580
- References
- 165
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 18 · 2023: 26 · 2022: 26 · 2021: 26 · 2020: 24 · 2019: 20 · 2018: 23 · 2017: 27 · 2016: 31 · 2015: 44 · 2014: 37 · 2013: 38 · 2012: 36
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychology Review (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, dopamine transporter, DRD4 gene, stimulant medication response, frontostriatal circuits, genome-wide linkage analysis, environmental etiology, developmental origins of health and disease, gene-environment interaction, prenatal stress, developmental neurotoxicity
- MeSH terms
- Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Brain Mapping, Dopamine, Humans, Molecular Biology, Nerve Tissue Proteins, Psychological Theory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review